Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

NCT01014351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Everolimus

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]